{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T06:10:01Z","timestamp":1737267001555,"version":"3.33.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1136\/ard.2007.081935","type":"journal-article","created":{"date-parts":[[2008,5,12]],"date-time":"2008-05-12T17:31:27Z","timestamp":1210613487000},"page":"903-904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Autoantibodies to cyclic citrullinated peptide in a PMR inception cohort from The PMR Outcomes Study"],"prefix":"10.1016","volume":"67","author":[{"given":"B","family":"Dasgupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Hutchings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Hollywood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Nutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2007.081935_bib1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/art.22106","article-title":"Polymyalgia rheumatica: the mess we are now in and what we need to do about it.","volume":"55","author":"Dasgupta","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.081935_bib2","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1136\/ard.60.11.1021","article-title":"Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective study.","volume":"60","author":"Caporali","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.081935_bib3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2006.051391","article-title":"Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review.","volume":"65","author":"Avouac","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.081935_bib4","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/rheumatology\/keh143","article-title":"Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly onset rheumatoid arthritis and polymyalgia rheumatica.","volume":"43","author":"Lopez-Hoyos","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2007.081935_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.22777","article-title":"Clinical outcomes, quality of life and diagnostic uncertainty in the first year of polymyalgia rheumatica.","volume":"57","author":"Hutchings","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.081935_bib6","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/art.10436","article-title":"Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: a highly effective test for the diagnosis of rheumatoid arthritis.","volume":"46","author":"Vincent","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.081935_bib7","first-page":"270","article-title":"Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey.","volume":"35","author":"Dasgupta","year":"2008","journal-title":"J Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724437357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724437357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2007.081935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T05:28:59Z","timestamp":1737264539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724437357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":7,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0003496724437357"],"URL":"https:\/\/doi.org\/10.1136\/ard.2007.081935","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies to cyclic citrullinated peptide in a PMR inception cohort from The PMR Outcomes Study","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2007.081935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 2008 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}